Overcoming Challenges and Barriers to Insulin Therapy in Type 2 Diabetes

,
Pharmacy Times, May 2015 Skin & Eye Health, Volume 81, Issue 5

This activity is supported by an educational grant from sanofi-aventis U.S.

Overcoming Challenges and Barriers to Insulin Therapy in Type 2 Diabetes

Faculty

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP

Professor of Pharmacy Practice

School of Pharmacy

MCPHS University

Boston, Massachusetts

Donna Horn, RPh, DPh

Adjunct Instructor

Department of Pharmacy Practice

School of Pharmacy

MCPHS University

Boston, Massachusetts

Educational Objectives:

After completing this continuing education program, the participant will be able to:

  • Explain barriers for the appropriate use of basal insulin to promote patient adherence to therapy.
  • Differentiate between the different pharmacokinetic and pharmacodynamics actions of available and emerging insulin agents.
  • Determine the potential role for new and emerging insulin therapies and dosage strengths for treatment of type 2 diabetes mellitus.
  • Illustrate insulin administration errors, and explain how effective patient counseling surrounding treatment regimens can reduce errors.

Target audience:

Pharmacists

Type of activity:

Application

Release date:

May 6, 2015

Expiration date:

May 6, 2017

Estimated time to complete activity

: 2.0 hours

Fee:

Free

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-040-H01-P. The activity is available for CE credit through May 6, 2017.